Burman CF - Search Results

Year	Number of Results
1999	2
2000	1
2002	1
2006	1
2007	2
2009	1
2010	1
2011	1
2012	1
2013	2
2014	1
2015	1
2016	2
2017	2
2018	2
2019	3
2020	1
2021	5
2022	4
2023	2
2024	2

1

Estimands and Complex Innovative Designs.

Collignon O, Schiel A, Burman CF, Rufibach K, Posch M, Bretz F. Collignon O, et al. Among authors: burman cf. Clin Pharmacol Ther. 2022 Dec;112(6):1183-1190. doi: 10.1002/cpt.2575. Epub 2022 Mar 29. Clin Pharmacol Ther. 2022. PMID: 35253205 Free PMC article. Review.

2

Modestly weighted logrank tests.

Magirr D, Burman CF. Magirr D, et al. Among authors: burman cf. Stat Med. 2019 Sep 10;38(20):3782-3790. doi: 10.1002/sim.8186. Epub 2019 May 26. Stat Med. 2019. PMID: 31131462

3

Optimized adaptive enrichment designs.

Ondra T, Jobjörnsson S, Beckman RA, Burman CF, König F, Stallard N, Posch M. Ondra T, et al. Among authors: burman cf. Stat Methods Med Res. 2019 Jul;28(7):2096-2111. doi: 10.1177/0962280217747312. Epub 2017 Dec 18. Stat Methods Med Res. 2019. PMID: 29254436 Free PMC article.

4

Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week.

Gregson J, Sharples L, Stone GW, Burman CF, Öhrn F, Pocock S. Gregson J, et al. Among authors: burman cf. J Am Coll Cardiol. 2019 Oct 22;74(16):2102-2112. doi: 10.1016/j.jacc.2019.08.1034. J Am Coll Cardiol. 2019. PMID: 31623769 Free article. Review.

5

Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL.

Koenig F, Spiertz C, Millar D, Rodríguez-Navarro S, Machín N, Van Dessel A, Genescà J, Pericàs JM, Posch M; EU-PEARL Consortium. Koenig F, et al. EClinicalMedicine. 2023 Dec 26;67:102384. doi: 10.1016/j.eclinm.2023.102384. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38226342 Free PMC article. Review.

6

Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome.

Collignon O, Burman CF, Posch M, Schiel A. Collignon O, et al. Among authors: burman cf. Clin Pharmacol Ther. 2021 Aug;110(2):311-320. doi: 10.1002/cpt.2183. Epub 2021 Mar 16. Clin Pharmacol Ther. 2021. PMID: 33506495 Free PMC article. Review.

7

A framework for assessing the impact of accelerated approval.

Gould AL, Campbell RK, Loewy JW, Beckman RA, Dey J, Schiel A, Burman CF, Zhou J, Antonijevic Z, Miller ER, Tang R. Gould AL, et al. Among authors: burman cf. PLoS One. 2022 Jun 24;17(6):e0265712. doi: 10.1371/journal.pone.0265712. eCollection 2022. PLoS One. 2022. PMID: 35749431 Free PMC article.

8

Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.

Hilgers RD, Bogdan M, Burman CF, Dette H, Karlsson M, König F, Male C, Mentré F, Molenberghs G, Senn S. Hilgers RD, et al. Among authors: burman cf. Orphanet J Rare Dis. 2018 May 11;13(1):77. doi: 10.1186/s13023-018-0820-8. Orphanet J Rare Dis. 2018. PMID: 29751809 Free PMC article. Review.

9

Selection bias, investment decisions and treatment effect distributions.

Wiklund SJ, Burman CF. Wiklund SJ, et al. Among authors: burman cf. Pharm Stat. 2021 Nov;20(6):1168-1182. doi: 10.1002/pst.2132. Epub 2021 May 17. Pharm Stat. 2021. PMID: 34002467 Free PMC article.

10

The MaxCombo Test Severely Violates the Type I Error Rate.

Magirr D, Burman CF. Magirr D, et al. Among authors: burman cf. JAMA Oncol. 2023 Apr 1;9(4):571-572. doi: 10.1001/jamaoncol.2022.7747. JAMA Oncol. 2023. PMID: 36757691 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year